日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation

在具有基因组缺陷和高炎症水平的肿瘤中,使用ceralasertib抑制ATR可产生持久疗效。

Dillon, Magnus T; Guevara, Jeane; Mohammed, Kabir; Patin, Emmanuel C; Smith, Simon A; Dean, Emma; Jones, Gemma N; Willis, Sophie E; Petrone, Marcella; Silva, Carlos; Thway, Khin; Bunce, Catey; Roxanis, Ioannis; Nenclares, Pablo; Wilkins, Anna; McLaughlin, Martin; Jayme-Laiche, Adoracion; Benafif, Sarah; Nintos, Georgios; Kwatra, Vineet; Grove, Lorna; Mansfield, David; Proszek, Paula; Martin, Philip; Moore, Luiza; Swales, Karen E; Banerji, Udai; Saunders, Mark P; Spicer, James; Forster, Martin D; Harrington, Kevin J

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial

IgE 抗体 MOv18 对表达叶酸受体-α 的晚期实体瘤患者的安全性和抗肿瘤活性:一项 I 期试验

James Spicer, Bristi Basu, Ana Montes, Udai Banerji, Rebecca Kristeleit, Rowan Miller, Gareth J Veal, Christopher J Corrigan, Stephen J Till, Mariangela Figini, Silvana Canevari, Claire Barton, Paul Jones, Sarah Mellor, Simon Carroll, Chris Selkirk, George Nintos, Vineet Kwatra, Ionut-Gabriel Funing